MILAN – President Donald Trump is not yet on a clear path to recovery from COVID-19 and some of his vital signs over the last 24 hours were very concerning, a person familiar with his health said on Saturday.
The source’s assessment of the Republican president’s medical status came after a team of doctors told reporters at a press conference earlier on Saturday that he was ‘doing very well’.
One of those doctors said Trump had told ‘I feel like I could walk out of here today’.
The source, who asked not to be identified, said the next 48 hours will be critical in terms of Trump’s care.
Trump, 74, left, the White House and was moved to Walter Reed National Military Medical Center near Washington on Friday just hours after he was diagnosed with COVID-19.
The New York Times said the decision to transport Trump to the hospital came after he had experienced difficulty breathing and his oxygen level dropped, prompting his doctors to give him supplemental oxygen, according to two sources that the newspaper were close to the White House.
White House doctor Sean P. Conley told reporters outside the hospital on Saturday that Trump had not experienced difficulty breathing, and was not given oxygen at Walter Reed.
‘The team and I are extremely happy with the progress the president has made’, Conley said. He declined to give a timetable for Trump’s possible release from the hospital.
Trump tweeted praise for the medical staff at Walter Reed, and other institutions that have joined them, saying they are ‘amazing’ and that with their help, ‘I am feeling well’.
The White House has said Trump will work in a special suite at the hospital for the next few days as a precautionary measures. He has no public events scheduled on Saturday.
The diagnosis was the latest setback for the Republican president, who is trailing Democratic rival Joe Biden in opinion polls ahead of the Nov.3 presidential election.
Trump has downplayed the threat of the coronavirus pandemic from the outset, even as the disease has killed more than 200,000 Americans and hammered the U.S. economy.
Conley said Trump had received a first dose of a five-day course of Remdesivir, an intravenous antiviral drug sold by Gilead Science Inc that has been shown to shorten hospital says. He is also taking an experimental treatment, Regeneron’s, one of several experimental COVID-19 drug known as monoclonal antibodies, as well as zinc, Vitamin D, famotidine, melatonin and aspirin, Conley had said.
Trump announced on Twitter early on Friday that he and the first lady, Melania Trump, had contracted the virus.